0 of 5 questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading...
You must sign in or sign up to start the quiz.
You have to finish following quiz, to start this quiz:
Currently, how confident are you in your ability to:
1 = not confident, 2 = somewhat confident, 3 = confident, 4 = very confident, 5 = extremely confident, N/A = not applicable to me
Develop personalized treatment plans for patients with dyslipidemia while incorporating PCSK9 inhibitor therapeutics?
Apply PCSK9 inhibitor therapeutics when treating patients with dyslipidemia?
Indicate how often you CURRENTLY use the following clinical practice strategy for your patients with dyslipidemia.
*1 = Never, 2 = Not often, 3 = Sometimes, 4 = Often, 5 = Always, N/A = Not applicable to me
Incorporate PCSK9 inhibitors to reduce cardiovascular risk.
1. The IMPROVE-IT Trial dosed patients to 40mg simvastatin or to both 10mg ezetimibe and 40mg simvastatin. Which of the following represents the difference between the LDL treatment groups?
2. On average, what was the duration of the IMPROVE-IT Trial?
3. Which of the following represents the percentage decrease of LDL cholesterol in the GLAGOV Trial?